Cas:96600-76-9 4-chloro-1-methyl-2-oxoquinoline-3-carbaldehyde manufacturer & supplier

Chemical Name:4-chloro-1-methyl-2-oxoquinoline-3-carbaldehyde

CAS.NO:96600-76-9

Synonyms:4-chloro-3-formyl-1-methyl-2(1H)-quinolone;1-methyl-4-chloro-3-formylquinolin-2-one;4-Chloro-1-methyl-2-oxo-1,2-dihydroquinoline-3-carbaldehyde;4-Chloro-3-formyl-1-methyl-2(1H)-quinolinone;N-methyl-2-oxoquinoline-3-carbaldehyde

Molecular Formula:C₁₁H₈ClNO₂

Molecular Weight:221.64000

HS Code:2933790090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:39.07000

Exact Mass:221.02400

LogP:2.00440

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 4-chloro-3-formyl-1-methyl-2(1H)-quinolone chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,N-methyl-2-oxoquinoline-3-carbaldehyde physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-Chloro-1-methyl-2-oxo-1,2-dihydroquinoline-3-carbaldehyde Use and application,1-methyl-4-chloro-3-formylquinolin-2-one technical grade,usp/ep/jp grade.

Related News: This dosage form may also support combination therapy modalities.? To date, over 400 patients have been dosed with the oral formulation of rigosertib in clinical trials.? Combination therapy of oral rigosertib with azacitidine, the standard of care in HR-MDS, has also been studied. Currently, oral rigosertib is being developed as a combination therapy together with azacitidine for patients with higher-risk MDS who require HMA therapy.? 4-chloro-1-methyl-2-oxoquinoline-3-carbaldehyde manufacturer Pharmaceutical intermediates: chemical raw materials or chemical products used in the process of pharmaceutical synthesis, are intermediate products in the process of producing APIs, and can be further processed into APIs. 4-chloro-1-methyl-2-oxoquinoline-3-carbaldehyde supplier At present, Linhai, Zhejiang Province, has established a national chemical raw material base in Zhejiang Province, which is the earliest and largest gathering area of ??domestic chemical raw material medicines and pharmaceutical intermediate industries. 4-chloro-1-methyl-2-oxoquinoline-3-carbaldehyde vendor The upstream industry for the R & D, production and sales of pharmaceutical intermediates is the basic chemical raw material industry, and the downstream industry is the chemical bulk drug and chemical pharmaceutical preparation industry. 4-chloro-1-methyl-2-oxoquinoline-3-carbaldehyde factory At present, Linhai, Zhejiang Province, has established a national chemical raw material base in Zhejiang Province, which is the earliest and largest gathering area of ??domestic chemical raw material medicines and pharmaceutical intermediate industries.